Literature DB >> 21949600

Outlier-Based Differential Expression Analysis in Proteomics Studies.

Huy Vuong1, Kerby Shedden, Yashu Liu, David M Lubman.   

Abstract

An active area in cancer biomarker research is the development of statistical methods to identify expression signatures reflecting the heterogeneity of cancer across affected individuals. Tomlins et al. [5] observed heterogeneous patterns of oncogene activation within several cancer types, and introduced a statistical method called Cancer Outlier Profile Analysis (COPA) to identify "cancer outlier genes". Several related statistical approaches have since been developed, but the operating characteristics of these procedures (e.g. power, false positive rate), have not yet been fully characterized, especially in a proteomics setting. Here, we use simulation to identify the degree to which an outlier pattern of differential expression must hold in order for outlier-based approaches to be more effective than mean-based approaches. We also propose a diagnostic procedure that characterizes the potentially unequal levels of differential expression in the tails and in the center of a distribution of expression values. We find that for sample sizes and effect sizes typical of proteomics studies, the outlier pattern must be strong in order for outlier-based analysis to provide a meaningful benefit. This is corroborated by analysis of proteomics data from a melanoma study, in which the differential expression is most often present throughout the distribution, rather than being concentrated in the tails, albeit with a few proteins showing expression patterns consistent with outlier expression.

Entities:  

Year:  2011        PMID: 21949600      PMCID: PMC3179374          DOI: 10.4172/jpb.1000177

Source DB:  PubMed          Journal:  J Proteomics Bioinform        ISSN: 0974-276X


  16 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Outlier sums for differential gene expression analysis.

Authors:  Robert Tibshirani; Trevor Hastie
Journal:  Biostatistics       Date:  2006-05-15       Impact factor: 5.899

3.  Cancer outlier differential gene expression detection.

Authors:  Baolin Wu
Journal:  Biostatistics       Date:  2006-10-04       Impact factor: 5.899

4.  MOST: detecting cancer differential gene expression.

Authors:  Heng Lian
Journal:  Biostatistics       Date:  2007-11-29       Impact factor: 5.899

5.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

6.  The distribution-based p-value for the outlier sum in differential gene expression analysis.

Authors:  Lin-An Chen; Dung-Tsa Chen; Wenyaw Chan
Journal:  Biometrika       Date:  2010-01-25       Impact factor: 2.445

7.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Authors:  C M Balch; S J Soong; J E Gershenwald; J F Thompson; D S Reintgen; N Cascinelli; M Urist; K M McMasters; M I Ross; J M Kirkwood; M B Atkins; J A Thompson; D G Coit; D Byrd; R Desmond; Y Zhang; P Y Liu; G H Lyman; A Morabito
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

8.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

9.  LSOSS: Detection of Cancer Outlier Differential Gene Expression.

Authors:  Yupeng Wang; Romdhane Rekaya
Journal:  Biomark Insights       Date:  2010-08-05

10.  Heterogeneity in cancer: cancer stem cells versus clonal evolution.

Authors:  Mark Shackleton; Elsa Quintana; Eric R Fearon; Sean J Morrison
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

View more
  2 in total

1.  f-divergence cutoff index to simultaneously identify differential expression in the integrated transcriptome and proteome.

Authors:  Shaojun Tang; Martin Hemberg; Ertugrul Cansizoglu; Stephane Belin; Kenneth Kosik; Gabriel Kreiman; Hanno Steen; Judith Steen
Journal:  Nucleic Acids Res       Date:  2016-03-14       Impact factor: 16.971

2.  Detection of patient subgroups with differential expression in omics data: a comprehensive comparison of univariate measures.

Authors:  Maike Ahrens; Michael Turewicz; Swaantje Casjens; Caroline May; Beate Pesch; Christian Stephan; Dirk Woitalla; Ralf Gold; Thomas Brüning; Helmut E Meyer; Jörg Rahnenführer; Martin Eisenacher
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.